ワクチンバイアル市場：タイプ別（マルチドーズ、シングルドーズ）、素材別（ガラス、ポリマー）、容量別、用途別-2023-2030年の世界予測

ワクチンバイアルの世界市場は大きく成長し、2023年には6億2,996万米ドル、CAGR 10.82%と予測され、2030年には12億9,547万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のワクチンバイアル市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.ワクチンバイアルの世界市場規模および予測は？

2.予測期間中、世界のワクチンバイアル市場を形成するCOVID-19の阻害要因と影響は？

3.ワクチンバイアルの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.ワクチンバイアルの世界市場における競争戦略は？

5.ワクチンバイアルの世界市場における技術動向と規制の枠組みは？

6.ワクチンバイアルの世界市場における主要ベンダーの市場シェアは？

7.ワクチンバイアルの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 感染症の蔓延とワクチンの需要の高さ
    • ワクチン接種を進めるための政府および民間団体の取り組みの拡大
  • 抑制要因
    • ヘルスケアインフラの欠如
  • 機会
    • 高性能パッケージングソリューションに対する嗜好の高まり
    • ワクチンの安全性を確保するためにvvmの重要性が高まる
  • 課題
    • ワクチンバイアルのサプライチェーンに関連する高コスト
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ
  • バリューチェーン分析

第6章 ワクチンバイアル市場：タイプ別

• 複数回投与
• 単回投与

第7章 ワクチンバイアル市場：素材別

• ガラス
• ポリマー

第8章 ワクチンバイアル市場：容量別

• 10ml
• 20ml
• 2ml
• 3ml
• 5ml

第9章 ワクチンバイアル市場：用途別

• 予防ワクチン
• 治療用ワクチン

第10章 南北アメリカのワクチンバイアル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のワクチンバイアル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのワクチンバイアル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. VACCINE VIALS MARKET RESEARCH PROCESS
• FIGURE 2. VACCINE VIALS MARKET SIZE, 2022 VS 2030
• FIGURE 3. VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. VACCINE VIALS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. VACCINE VIALS MARKET SIZE, BY MATERIAL, 2022 VS 2030 (%)
• FIGURE 6. VACCINE VIALS MARKET SIZE, BY CAPACITY, 2022 VS 2030 (%)
• FIGURE 7. VACCINE VIALS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. VACCINE VIALS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. VACCINE VIALS MARKET DYNAMICS
• FIGURE 10. VACCINE VIALS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. VACCINE VIALS MARKET SIZE, BY MATERIAL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. VACCINE VIALS MARKET SIZE, BY CAPACITY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. VACCINE VIALS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. VACCINE VIALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 8. VACCINE VIALS MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. VACCINE VIALS MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 11. VACCINE VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. VACCINE VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. VACCINE VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. VACCINE VIALS MARKET SIZE, BY 3ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. VACCINE VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 34. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 35. CANADA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 56. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 57. CHINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 60. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 61. INDIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. TAIWAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. THAILAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. VIETNAM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. DENMARK VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. EGYPT VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. FINLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. ISRAEL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 129. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 130. ITALY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. NIGERIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. NORWAY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. POLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. POLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 145. POLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 146. POLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. QATAR VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. QATAR VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 149. QATAR VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 150. QATAR VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. RUSSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SPAIN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SWEDEN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SWITZERLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. TURKEY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 188. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 189. VACCINE VIALS MARKET LICENSE & PRICING

The Global Vaccine Vials Market is forecasted to grow significantly, with a projected USD 629.96 million in 2023 at a CAGR of 10.82% and expected to reach a staggering USD 1,295.47 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Vaccine Vials Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Vaccine Vials Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Multi Dose and Single Dose. The Multi Dose is projected to witness significant market share during forecast period.

Based on Material, market is studied across Glass and Polymer. The Polymer is projected to witness significant market share during forecast period.

Based on Capacity, market is studied across 10ml, 20ml, 2ml, 3ml, and 5ml. The 3ml is projected to witness significant market share during forecast period.

Based on Application, market is studied across Preventive Vaccine and Therapeutic Vaccine. The Therapeutic Vaccine is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Vaccine Vials Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Vaccine Vials Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccine Vials Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccine Vials Market?

4. What is the competitive strategic window for opportunities in the Global Vaccine Vials Market?

5. What are the technology trends and regulatory frameworks in the Global Vaccine Vials Market?

6. What is the market share of the leading vendors in the Global Vaccine Vials Market?

7. What modes and strategic moves are considered suitable for entering the Global Vaccine Vials Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Vaccine Vials Market, by Type, 2022 vs 2030
• 4.3. Vaccine Vials Market, by Material, 2022 vs 2030
• 4.4. Vaccine Vials Market, by Capacity, 2022 vs 2030
• 4.5. Vaccine Vials Market, by Application, 2022 vs 2030
• 4.6. Vaccine Vials Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High prevalence of infectious diseases and demands for number of vaccines
    • 5.1.1.2. Growing initiatives from government and private organizations to advance vaccination
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of healthcare infrastructure
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising preference for high performance packaging solutions
    • 5.1.3.2. Increasing importance of vvm to ensure vaccine safety
  • 5.1.4. Challenges
    • 5.1.4.1. High-cost associated with the supply chain of vaccine vials
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization
  • 5.9.1. Value Chain Analysis

6. Vaccine Vials Market, by Type

• 6.1. Introduction
• 6.2. Multi Dose
• 6.3. Single Dose

7. Vaccine Vials Market, by Material

• 7.1. Introduction
• 7.2. Glass
• 7.3. Polymer

8. Vaccine Vials Market, by Capacity

• 8.1. Introduction
• 8.2. 10ml
• 8.3. 20ml
• 8.4. 2ml
• 8.5. 3ml
• 8.6. 5ml

9. Vaccine Vials Market, by Application

• 9.1. Introduction
• 9.2. Preventive Vaccine
• 9.3. Therapeutic Vaccine

10. Americas Vaccine Vials Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Vaccine Vials Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Vaccine Vials Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing